• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

KANE BIOTECH INC

Notes

No. Proposition For Against Abstain
1

ELECTION OF DIRECTOR: RENAUD, PHILIP

2

ELECTION OF DIRECTOR: COLEMAN, JOHN

3

ELECTION OF DIRECTOR: HUIZINGA, ROBERT

4

ELECTION OF DIRECTOR: GREVEN, ANNE

5

ELECTION OF DIRECTOR: RAMPERTAB, SHAMEZE

6

ELECTION OF DIRECTOR: KIDECKEL, DAVID

7

APPOINTMENT OF MNP LLP AS AUDITORS AND TO AUTHORIZE THE BOARD OF DIRECTORS TO FIX THEIR REMUNERATION

8

TO APPROVE THE FOURTH AMENDED AND RESTATED PERFORMANCE AND RESTRICTED SHARE UNIT PLAN OF THE COMPANY

9

TO APPROVE THE THIRD AMENDED AND RESTATED STOCK OPTION PLAN OF THE COMPANY

10

TO RATIFY THE SECOND AMENDED AND RESTATED BY-LAW NO.1 OF THE COMPANY